Trial Profile
A study to evaluate the activity of cabazitaxel in patients with castration-resistant prostate cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 09 Dec 2015 New trial record